Trial · NCT07434934
Registered outcomes20
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 20
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Gait Velocity- single-task (BTS GAITLAB) | six weeks | Measured using BTS GAITLAB (Physiotherapy Laboratory, University of Sharjah) during walking under single-task condition (walking only). Report mean gait velocity across trials. Higher = faster walking. |
| Primary | Gait velocity during dual-task walking (m/s) | 6 weeks | Measured using BTS GAITLAB during walking under dual-task cognitive condition. Report mean gait velocity across trials. Higher = faster walking under dual-task. |
| Secondary | Balance - Berg Balance Scale (BBS) | Six weeks | Balance assessed using the Berg Balance Scale. Report total score (0-56). Higher = better balance. |
| Secondary | Activities-specific Balance Confidence (ABC) Scale score (0-100%) | 6 weeks | Balance confidence assessed using the ABC scale. Report total/mean percentage score (0-100%). Higher = greater confidence. |
| Secondary | Five Times Sit-to-Stand test time (seconds) | 6 weeks | Functional lower-limb performance assessed using five times chair sit-to-stand test. Report completion time in seconds. Lower = better. |
| Secondary | Functional Mobility Scale (FMS) rating | 6 weeks | Functional mobility assessed using the Functional Mobility Scale. Report FMS rating (per standard scoring). Higher = better mobility. |
| Secondary | Biodex Balance System stability index (unit per device output) | 6 weeks | Instrumented balance assessed using the Biodex Medical Balance System (Physiotherapy Laboratory, University of Sharjah). Report stability index as provided by the device. Interpret direction as per device metric (lower = better stability). |
| Secondary | Daily step count measured by FIBION (steps/day) | 6 weeks | Physical activity assessed using FIBION activity monitor worn 7 consecutive days / 24 h before and after intervention. Report mean daily step count over the monitoring period. Higher = more activity. |
| Secondary | Modified Physical Activity Scale (M-PAS) score | 6 weeks | Self-reported physical activity assessed using M-PAS. Report total score (per instrument scoring). Specify direction per scoring (higher = more activity). |
| Secondary | Falls Efficacy Scale-International (FES-I) total score | 6 weeks | Fall concern assessed using FES-I. Report total score (per instrument scoring). Higher = greater concern about falling (worse). |
| Secondary | Modified Fatigue Impact Scale (MFIS) total score | 6 weeks | Fatigue assessed using MFIS. Report total score (per instrument scoring). Higher = worse fatigue impact. |
| Secondary | Short Form-36 (SF-36) health-related quality of life score | 6 weeks | Quality of life assessed using SF-36. Report domain scores and/or Physical and Mental Component Summary scores (per SF-36 scoring). Higher = better health status. |
| Secondary | Hospital Anxiety and Depression Scale (HADS-A) score (0-21) | 6 weeks | Anxiety symptoms assessed using HADS Anxiety subscale. Report subscale score (0-21). Higher = worse anxiety symptoms. |
| Secondary | Hospital Anxiety and Depression Scale (HADS-D) score (0-21) | 6 weeks | Depressive symptoms assessed using HADS Depression subscale. Report subscale score (0-21). Higher = worse depressive symptoms. |
| Secondary | 6-Minute Walk Test distance (meters) | 6 weeks | Physical performance assessed using the 6-minute walking test. Report distance walked in meters. Higher = better walking endurance. |
| Secondary | Montreal Cognitive Assessment (MoCA) total score (0-30) | 6 weeks | Global cognitive function assessed using the MoCA. Report total score (0-30). Higher = better cognition. |
| Secondary | Symbol Digit Modalities Test (SDMT) score (correct responses) | 6 weeks | Processing speed assessed using SDMT (BICAMS component). Report total correct responses (per scoring). Higher = better. |
| Secondary | Hopkins Verbal Learning Test-II (HVLT-II) total recall score | 6 weeks | Verbal learning/memory assessed using HVLT-II (BICAMS component). Report total recall score (per scoring). Higher = better. |
| Secondary | Brief Visuospatial Memory Test-Revised (BVMT-R) total recall score | 6 weeks | Visuospatial memory assessed using BVMT-R (BICAMS). Report total recall score (per scoring). Higher = better memory. |
| Secondary | Stroop test interference score (per protocol) | 6 weeks | Inhibitory control assessed using the Stroop test. Report interference score. lower interference score = better |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07434934/registered